Kamada, Tomoari
Satoh, Kiichi
Itoh, Toshiyuki
Ito, Masanori
Iwamoto, Junichi
Okimoto, Tadayoshi
Kanno, Takeshi
Sugimoto, Mitsushige
Chiba, Toshimi
Nomura, Sachiyo
Mieda, Mitsuyo
Hiraishi, Hideyuki
Yoshino, Junji
Takagi, Atsushi
Watanabe, Sumio
Koike, Kazuhiko
Article History
Received: 7 October 2020
Accepted: 3 February 2021
First Online: 23 February 2021
Compliance with ethical standards
:
: Any financial relationship with enterprises, businesses or academic institutions in the subject matter or materials discussed in the manuscript are listed as follows: (1) those from whom the authors, the spouse, partner or immediate relatives of authors, who have received individually any income, honoraria or any other types of remuneration: Astellas Pharma Inc., AstraZeneca K.K., DaiichiSankyo Company, Limited, Eisai Co., Ltd., Otsuka Pharmaceutical Co.,Ltd., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited. and (2) those from whom the academic institutions of the authors received support (commercial/academic cooperation): Ajinomoto Pharmaceuticals Co., Ltd., AsTellas Pharma Inc., AstraZenecaK. K., Bayer Yakuhin, Ltd., Chugai PharmaCeutical Co., Ltd., DaiichiSankyo Company, Limited, Eisai Co., Ltd., Kishuhosokawa Co., Ltd., Maruso Co., Ltd, Mitsubishi Tanabe Pharma Corporation, MSD K.K., Nihon Pharmaceutical Co. Ltd., Nippon Shinyaku Co., Ltd., Okahatanoen Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sanofi K.K., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical.